Lv1
50 积分 2024-09-01 加入
B细胞靶向药物治疗风湿免疫病中国专家共识（2024版）
10天前
已完结
Autoimmune pathogenesis, immunosuppressive therapy and pharmacological mechanism in aplastic anemia
18天前
已完结
Efficacy and Safety of Donidalorsen for Hereditary Angioedema
20天前
已完结
Prophylactic use of an anti-activated factor XII monoclonal antibody, garadacimab, for patients with C1-esterase inhibitor-deficient hereditary angioedema
20天前
已完结
中国急性缺血性卒中诊治指南2023
20天前
已完结
Alternative Complement Pathway Inhibition with Iptacopan in IgA Nephropathy
22天前
已完结
Garadacimab for hereditary angioedema attack prevention: long-term efficacy, quality of life, and safety data from a phase 2, randomised, open-label extension study
24天前
已完结
Tarlatamab Sustained Clinical Benefit and Safety in Previously Treated SCLC: DeLLphi-301 Phase 2 Extended Follow-up
29天前
已关闭
Aplastic anemia: Pathophysiology
1个月前
已完结
Inhibition of IL-13: A New Pathway for Atopic Dermatitis
2个月前
已完结
皖公网安备34019202002308
